Latest Vanderbilt University Medical Center Stories
Experts have found that women in China who had breast cancer and a higher intake of soy food had an associated lower risk of death and breast cancer recurrence.
A drug used to treat colorectal cancer also can reverse a rare stomach disorder and should be considered first-line therapy for the disease.
A multi-national research team has discovered that two genetic factors converge to increase the risk of sudden cardiac death.
A new report shows that kidney transplant patients have a weaker response to flu vaccines than healthy individuals, especially in the first six months after receiving a transplant.
A team of Vanderbilt University Medical Center investigators has cracked one of clinical medicine's enduring mysteries â€“ what happened to the tuberculosis vaccine.
As most of the nationâ€™s hospitals deal with a shortage of nurses, some are taking steps to make sure new nurses donâ€™t become overwhelmed.
A team of Vanderbilt University Medical Center investigators has developed a group of chemical compounds that could represent a new class of drugs for treating cancer.
Vanderbilt University Medical Center investigators have found a surprising link between brain iron levels and serotonin, a neurotransmitter involved in neuropsychiatric conditions ranging from autism to major depression.
InteRNA Technologies and VU university medical center in Amsterdam have signed a framework research agreement to develop microRNA-based diagnostics and therapeutics for cancer using InteRNA's proprietary library of miRNAs.
BILTHOVEN and AMSTERDAM, The Netherlands, October 30 /PRNewswire/ -- InteRNA Technologies B.V.
- A serpent whose bite was fabled to produce intense thirst.